Changeflow GovPing Healthcare & Life Sciences Prostate Cancer Screening Consultation Closes
Routine Notice Added Final

Prostate Cancer Screening Consultation Closes

Favicon for www.gov.uk UK National Screening Committee
Published
Detected
Email

Summary

The UK National Screening Committee (UK NSC) announced that its 12-week public consultation on prostate cancer screening has closed as of 24 February 2026. The consultation sought feedback on a 2025 modelling study examining screening impacts across all men in the UK, Black men, men with BRCA1/BRCA2 variants, and men with relevant family cancer history. Submitted responses will be analysed at the committee's March meeting before a final recommendation is made to ministers.

What changed

The UK NSC announced the closure of its public consultation on prostate cancer screening, which ran for 12 weeks and received hundreds of responses from members of the public sharing personal experiences with prostate cancer diagnoses. The consultation sought feedback on a 2025 modelling study by Sheffield School for Health and Related Research (SCHARR) examining screening impacts on specific population groups.

Affected parties including healthcare providers, public health authorities, and patients should monitor the UK NSC prostate cancer recommendation page for the final recommendation, which will be published following the committee's March meeting and subsequent ministerial decision. This notice does not create immediate compliance obligations but signals potential future changes to UK prostate cancer screening policy.

What to do next

  1. Monitor the UK NSC prostate cancer recommendation page for the finalised recommendation

Archived snapshot

Apr 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

News story

UK NSC consultation on prostate cancer screening closes

The 12-week public consultation that opened on Friday 28 November 2025 has closed.

From: UK National Screening Committee Published 24 February 2026

The UK National Screening Committee (UK NSC) has received hundreds of responses to the public consultation on screening for prostate cancer, which has now closed.

Consultation comments are no longer being accepted. However, the evidence review documents can still be viewed via this UK NSC Blog article that was published when the consultation opened.

Responses submitted will be analysed and considered by the UK NSC at its March meeting. Subject to the consultation feedback, the committee will make a final recommendation on screening for prostate cancer to ministers who will decide on next steps.

People were asked to provide feedback on a 2025 modelling study and its conclusions. The study, commissioned by the UK NSC and undertaken by the Sheffield School for Health and Related Research (SCHARR), examined the impact of screening for prostate cancer on:

  • all men in the UK
  • Black men
  • men with a known BRCA1 or BRCA2 gene variant
  • men with a relevant family history of cancer Many of the responses received came from members of the public, sharing their experience of a prostate cancer diagnosis – either their own story, or that of a loved one. Thank you to everyone who took the time to respond to the consultation.

Consultation responses and the finalised UK NSC recommendation on screening for prostate cancer will be published on the UK NSC’s prostate cancer recommendation page in due course.

Share this page

The following links open in a new tab

Updates to this page

Published 24 February 2026

Get daily alerts for UK National Screening Committee

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from UK NSC.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
UK NSC
Published
February 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Public health authorities Healthcare providers Patients
Industry sector
6211 Healthcare Providers
Activity scope
Public health screening Cancer screening programmes Population health assessment
Geographic scope
United Kingdom GB

Taxonomy

Primary area
Public Health
Operational domain
Regulatory Affairs
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when UK National Screening Committee publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!